| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 82.670 | 38.370 | 43.323 | 60.355 | 56.941 | 60.844 |
| Total Income - EUR | - | - | - | 0 | 82.670 | 46.112 | 55.958 | 60.357 | 56.942 | 60.846 |
| Total Expenses - EUR | - | - | - | 2.993 | 75.050 | 134.111 | 44.440 | 49.071 | 51.531 | 51.555 |
| Gross Profit/Loss - EUR | - | - | - | -2.993 | 7.620 | -87.999 | 11.519 | 11.286 | 5.411 | 9.291 |
| Net Profit/Loss - EUR | - | - | - | -2.993 | 6.794 | -88.458 | 11.085 | 10.682 | 4.841 | 7.465 |
| Employees | - | - | - | 0 | 2 | 5 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Ambi Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 5.656 | 4.708 | 8.501 | 47.332 | 35.504 | 23.459 | 11.457 |
| Current Assets | - | - | - | 138 | 25.010 | 2.704 | 2.870 | 5.460 | 13.562 | 3.977 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 93 | 23.012 | 225 | 2.037 | 3.283 | 4.308 | 0 |
| Cash | - | - | - | 45 | 1.998 | 2.479 | 833 | 2.178 | 9.254 | 3.977 |
| Shareholders Funds | - | - | - | -2.950 | 3.900 | -84.810 | -71.844 | -61.385 | -56.357 | -48.577 |
| Social Capital | - | - | - | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | 8.744 | 25.818 | 96.579 | 122.254 | 102.350 | 94.024 | 64.371 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ambi Medica S.r.l.